These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14613302)

  • 1. Treatment of renal amyloidosis in rheumatoid arthritis requires further investigation: comment on the case report by Elkayam et al.
    Ciboddo G; Idone C
    Arthritis Rheum; 2003 Nov; 48(11):3299; author reply 3299-300. PubMed ID: 14613302
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term followup needed to define role of infliximab in treatment of renal amyloidosis: comment on the case report by Elkayam et al.
    Tweezer-Zaks N; Langevitz P; Livneh A
    Arthritis Rheum; 2003 Nov; 48(11):3298-9; author reply 3299-300. PubMed ID: 14613300
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab.
    Elkayam O; Hawkins PN; Lachmann H; Yaron M; Caspi D
    Arthritis Rheum; 2002 Oct; 46(10):2571-3. PubMed ID: 12384913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al.
    Molenaar ET; Bultink IE; Dijkmans BA; Lems WF
    Arthritis Rheum; 2005 Apr; 52(4):1334-6. PubMed ID: 15818690
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal amyloidosis secondary to rheumatoid arthritis: remission of proteinuria and renal function improvement with tocilizumab.
    Vinicki JP; De Rosa G; Laborde HA
    J Clin Rheumatol; 2013 Jun; 19(4):211-3. PubMed ID: 23669800
    [No Abstract]   [Full Text] [Related]  

  • 6. Is IV infliximab better than IV methylprednisolone for the treatment of patients with RA when methotrexate fails?
    Smith MD
    Ann Rheum Dis; 2005 Mar; 64(3):512; author reply 512. PubMed ID: 15708914
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis.
    Gonzalez-Juanatey C; Llorca J; Garcia-Porrua C; Martin J; Gonzalez-Gay MA
    Arthritis Rheum; 2006 Feb; 55(1):150-3. PubMed ID: 16463428
    [No Abstract]   [Full Text] [Related]  

  • 8. Membranous glomerulopathy associated with rheumatoid arthritis may respond to rituximab.
    Pixley J; Wolf B; O'Neill W
    Scand J Rheumatol; 2008; 37(4):313-4. PubMed ID: 18612934
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis.
    Kerkeni S; Marotte H; Miossec P
    Muscle Nerve; 2008 Oct; 38(4):1343-5. PubMed ID: 18816604
    [No Abstract]   [Full Text] [Related]  

  • 10. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
    D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
    Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies.
    Teng YK; Tekstra J; Breedveld FC; Lafeber F; Bijlsma JW; van Laar JM
    Ann Rheum Dis; 2009 Jun; 68(6):1075-7. PubMed ID: 19435725
    [No Abstract]   [Full Text] [Related]  

  • 12. Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab.
    Ornetti P; Solau E; Gaudin P; Sibilia J; Berthelot JM; Puechal X; Tavernier C; Maillefert JF;
    Ann Rheum Dis; 2005 Sep; 64(9):1379-80. PubMed ID: 16100349
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals.
    Buch MH; Marzo-Ortega H; Bingham SJ; Emery P
    Rheumatology (Oxford); 2004 Feb; 43(2):243-4. PubMed ID: 14739466
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy].
    Dahlin J; Sørensen SF
    Ugeskr Laeger; 2003 Nov; 165(48):4646-9. PubMed ID: 14677464
    [No Abstract]   [Full Text] [Related]  

  • 15. How to dose infliximab in rheumatoid arthritis: new data on a serious issue.
    van Vollenhoven RF
    Ann Rheum Dis; 2009 Aug; 68(8):1237-9. PubMed ID: 19605741
    [No Abstract]   [Full Text] [Related]  

  • 16. Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration.
    Toki H; Momohara S; Tsukahara S; Ikari K
    J Rheumatol; 2008 Sep; 35(9):1896-7; author reply 1897. PubMed ID: 18785300
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Okamoto H
    N Engl J Med; 2006 Nov; 355(19):2047; author reply 2048. PubMed ID: 17099950
    [No Abstract]   [Full Text] [Related]  

  • 18. Timing of DAS28 in infliximab therapy.
    Armstrong DJ; Bruce IN
    Rheumatology (Oxford); 2005 Sep; 44(9):1203-4; author reply 1204. PubMed ID: 15870143
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
    Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactions to infliximab in patients with rheumatoid arthritis.
    Sakellariou GT; Chatzigiannis I
    J Rheumatol; 2005 Jul; 32(7):1411-2. PubMed ID: 15996088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.